Cargando…
Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia
BACKGROUND: The 2018 European Society of Cardiology (ESC)/European Society of Hypertension (ESH) guidelines for the management of hypertension highlight the importance of fixed-dose combinations (FDC) for the treatment of hypertension and recommend initial single-pill combination therapy in almost a...
Autores principales: | Mahfoud, Felix, Kieble, Marita, Enners, Salka, Kintscher, Ulrich, Laufs, Ulrich, Böhm, Michael, Schulz, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898344/ https://www.ncbi.nlm.nih.gov/pubmed/35220445 http://dx.doi.org/10.1007/s00392-022-01993-5 |
Ejemplares similares
-
Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany
por: Rudolph, Ulrike Maria, et al.
Publicado: (2020) -
Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012–2021
por: Katzmann, Julius L., et al.
Publicado: (2022) -
Utilization of drugs with reports on potential efficacy or harm on COVID‐19 before, during, and after the first pandemic wave
por: Enners, Salka, et al.
Publicado: (2021) -
Quality Appraisal of Ambulatory Oral Cephalosporin and Fluoroquinolone Use in the 16 German Federal States from 2014–2019
por: Gradl, Gabriele, et al.
Publicado: (2021) -
Comparing outpatient oral antibiotic use in Germany and the Netherlands from 2012 to 2016
por: Gradl, Gabriele, et al.
Publicado: (2018)